Curative Biosciences, Inc. (CBDX) Research

Curative Biosciences, Inc. is a company focused on innovating and bringing to market medical treatments that leverage Cannabidiol extracted from hemp. The firm aims to produce and distribute natural wellness products, establishing a significant presence within the therapeutic cannabis sector. Headquartered in Miami, Florida, the company was founded in 2009 and notably underwent a rebranding in August 2017, changing its name from the former Amaize Beverage Corporation.

Market snapshot

Symbol
CBDX
Price
$0.00
Day change
0.00%
Market cap
$25.8K
P/E ratio
-0.03x
52-week range
0.0001-0.0002
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Acura Pharmaceuticals, Inc. (ACUR)
  • Amazonas Florestal, Ltd (AZFL)
  • Cannonau Corp. (CNNC)
  • Filament Health Corp. (FLHLF)
  • G Medical Innovations Holdings Ltd (GMVDF)
  • Kali, Inc. (KALY)
  • Microart Inc. (MCRT)
  • Wayland Group Corp. (MRRCF)

Open Curative Biosciences, Inc. (CBDX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.